Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

In the first head-to-head trial of Ozempic versus Eli Lilly's new "King Kong" drug retatrutide, the next-generation drug led to more weight loss.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.businessinsider.com)